2018
2019
(in € millions)
Interim financial statements
as of June 30
Financial statements for the
year ended December 31
Interim financial statements
as of June 30
Non-current assets
(a)
4,236
4,669
4,148
Current assets
(a)
3,786
3,782
5,296
Equity
(a)
3,645
3,874
4,056
Non-current liabilities
(a)
1,118
1,384
908
Current liabilities
(a)
3,259
3,193
4,481
Sales
(a)
4,476
8,838
5,199
Net income
(a)
215
411
282
Other comprehensive income
(a)
(29)
(58)
(9)
(a) Published financial statements prepared in accordance with IFRS. Income statement items have been translated into euros at the average exchange
rate for the reporting period. Balance sheet items have been translated into euros at the exchange rate in effect at the end of the reporting period.
Impairment review as of December 31, 2019
The Group has not noted any indications of impairment. In particular, the stock price of the Mengniu group is still higher than the
average purchase price of its shares.
Impairment review as of December 31, 2018
The Group has not noted any indications of impairment.
Yashili (Specialized Nutrition, China)
Accounting treatment of the investment
This shareholding, acquired under the terms of the Group’s strategic agreement with Mengniu, is recognized under Investments in
associates. As of December 31, 2019, Danone held 25% of Yashili’s share capital, had significant influence over its operating policies
and was involved in its governance, in particular through its right to appoint two members of the board of directors and it proposed the
candidate for appointment as Chief Executive Officer. Consequently, its shareholding is recognized within Investments in associates.
Do'stlaringiz bilan baham: |